BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28698547)

  • 21. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
    Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress.
    Ryu S; Lim W; Bazer FW; Song G
    J Cell Physiol; 2017 Dec; 232(12):3786-3797. PubMed ID: 28213961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
    Almenara J; Rosato R; Grant S
    Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells.
    Reshma RS; Sreelatha KH; Somasundaram V; Satheesh Kumar S; Nadhan R; Nair RS; Srinivas P
    Pharmacol Res; 2016 Mar; 105():134-45. PubMed ID: 26808083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.
    Li B; Jin X; Meng H; Hu B; Zhang T; Yu J; Chen S; Guo X; Wang W; Jiang W; Wang J
    Oncotarget; 2017 Jul; 8(29):47849-47860. PubMed ID: 28599307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W; Fan J; Bertino JR
    Cancer Res; 2001 Mar; 61(6):2579-82. PubMed ID: 11289134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
    Jaworska D; Szliszka E
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.
    Kan SF; Yu CH; Pu HF; Hsu JM; Chen MJ; Wang PS
    J Cell Biochem; 2007 May; 101(1):44-56. PubMed ID: 17340628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells.
    Chen M; Zhou B; Zhong P; Rajamanickam V; Dai X; Karvannan K; Zhou H; Zhang X; Liang G
    Prostate; 2017 Apr; 77(5):489-504. PubMed ID: 27990666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethyl acetate fraction from methanol extraction of Vitis thunbergii var. taiwaniana induced G
    Lin CH; Chan HS; Tsay HS; Funayama S; Kuo CL; Chung JG
    Environ Toxicol; 2018 Jan; 33(1):41-51. PubMed ID: 28941016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.
    Tang NY; Huang YT; Yu CS; Ko YC; Wu SH; Ji BC; Yang JS; Yang JL; Hsia TC; Chen YY; Chung JG
    Anticancer Res; 2011 May; 31(5):1691-702. PubMed ID: 21617228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Ggamma/T-15 transgenic mouse model of prostate cancer.
    Reiner T; de las Pozas A; Perez-Stable C
    Prostate; 2006 Oct; 66(14):1487-97. PubMed ID: 16921509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
    Szliszka E; Helewski KJ; Mizgala E; Krol W
    Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
    Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
    Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
    Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
    Chien M; Astumian M; Liebowitz D; Rinker-Schaeffer C; Stadler WM
    Cancer Chemother Pharmacol; 1999; 44(1):81-7. PubMed ID: 10367753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
    Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
    Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway.
    Liu KC; Huang YT; Wu PP; Ji BC; Yang JS; Yang JL; Chiu TH; Chueh FS; Chung JG
    Int J Oncol; 2011 Mar; 38(3):787-96. PubMed ID: 21206973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.